Question · asked by 1 review
Low molecular weight heparin vs prostaglandin E1: Quality of life
- Population
- Patients undergoing stem cell transplant with malignant and non‐malignant diseases
- Intervention
- Low molecular weight heparin
- Comparison
- prostaglandin E1
- Outcome
- Quality of life
The review found no eligible studies for this question.
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Summary of findings: Low molecular weight heparin vs prostaglandin E1 Quality of life · People undergoing stem cell transplant with malignant and non‐malignant diseases The review found no eligible studies for this question. Interventions for prophylaxis of hepatic veno‐occlusive disease in people undergoing haematopoietic stem… (2015) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Interventions for prophylaxis of hepatic veno‐occlusive disease in people undergoing haematopoietic stem cell transplantation 2015 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Low molecular weight heparin vs placebo or no treatment · People undergoing stem cell transplant with malignant diseases · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.